EDUCATION > Educational Programs > Education for APN/PA/Allied Health > Spotlight on OAB

APN/PA Spotlight on OAB

OAB Educational Activity

Credit Designation: The American Urological Association Education and Research, Inc designate this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Status
Module 1 Overactive Bladder Posttest Available 1.00 credits/hours

Overview

While both the Physician Assistant programs and Advanced Practice Nursing programs do not always routinely provide substantial urology-specific training in their core educational curriculum, they are strong in basic physiology and diagnostics. Physician Assistants and Advanced Practice Nurses are excellent diagnosticians, which makes their role in general urology practices invaluable given the large disease prevalence. There is a need for education in the (i) pathophysiology of OAB (ii) advanced investigation of the OAB patient such as urodynamics and (iii) the use of therapeutic strategies for this condition. The basis of medical therapies has traditionally included simple anti-cholinergics, anti-muscarinics, but more recently has expanded to include more complex and effective Beta- 3 agonists, injection therapy such as Botox, and nerve stimulation techniques. This activity is designed to provide participants with an overview of the pathophysiology of OAB, advanced investigation of the OAB patient such as urodynamics and the use of therapeutic strategies for this condition.

Learning Objectives

Upon completion of this activity participants should be able to:

  1. Compare the wide array of clinical conditions associated with overactive bladder
  2. Perform a focused medical history and physical exam specific to the OAB patient
  3. Describe the role of adjuvant investigations and delineate when they are indicated
  4. Analyze the risks and benefits of OAB pharmacotherapies when treating patients
  5. Evaluate the role of advanced therapeutic strategies and timing of referral for such treatments

Target Audience

  • Physician Assistants
  • Advanced Practice Nurses
  • Registered Nurses
  • Medical Assistants

Method of Participation

Learners will participate in this interactive online educational activity by reading through slides and case studies, answering multiple choice questions, examining patient tools and resources and completing the posttest and evaluation. There is no fee to participate in this CME activity. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 1.0 hour

Release Date: February, 2014

Expiration Date: February, 2017

Software Requirements for Online Test

A PC-compatible computer running Windows XP, or a Macintosh computer running OS X 10.4 or later. Internet access. Adobe Acrobat Reader 9 or newer.

AUA Disclosure Policy

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Faculty

The content of this enduring material was developed by Allen D. Seftel, MD with contributions from Thomas McBride, PA-C.

Faculty Disclosures

Allen D. Seftel, MD: Auxilium: Consultant or Advisor, Scientific Study or Trial; Journal of Urology: Leadership Position; Abbott: Consultant or Advisor; Lilly: Consultant or Advisor, Scientific Study or Trial; Journal of Sexual Medicine: Leadership Position; American Geriatrics Society: Leadership Position; Urology Care Foundation: Leadership Position; Mid -Atlantic Section of AUA: Leadership Position; AUA NPP committee: Leadership Position; International Journal of Impotence Research: Leadership Position; Patient Pocket, LLC: Owner, Product Development.

Thomas P. McBride, PA-C: Adirondack Society of Physician Assistants: Leadership Position, Meeting Participant or Lecturer; Dendreon Corporation: Investment Interest; SeekingAlpha.com: Health Publishing

Planner Disclosures

Education Council

Christopher Lee Amling, MD: Janssen: Meeting Participant or Lecturer

Gopal Badlani, MD: Lithotripsy Group: Piedmont stone & Physician Discovery: Investment Interest; Society of University Urologist: Leadership Position; NIDDK: Leadership Position

Timothy Charles Brand, MD: Nothing to disclose

Peter Robert Carroll, MD: NIH: Scientific Study or Trial; Department of Defense: Scientific Study or Trial; Myriad Genetics: Scientific Study or Trial; Genomic Health: Scientific Study or Trial; Abbott Pharmaceuticals: Scientific Study or Trial; AUA Update: Leadership Position; Astra Zeneca: Meeting Participant or Lecturer; Genome Dx: Consultant or Advisor; Intuitive: Meeting Participant or Lecturer; Genomic Health: Consultant or Advisor; Takeda Pharmaceutical Company: Meeting Participant or Lecturer; Teva Pharmaceutical Industries: Meeting Participant or Lecturer; Janssen Pharmaceutical Companies: Meeting Participant or Lecturer; Intuitive Surgical Inc.: Meeting Participant or Lecturer

Sam S. Chang, MD: Janssen: Consultant or Advisor, Meeting Participant or Lecturer; Astellas: Consultant or Advisor; Dendreon: Consultant or Advisor; NIH: Scientific Study or Trial; Cold Genesys, Inc.: Scientific Study or Trial; Cepheid: Scientific Study or Trial

Pat Fox Fulgham, MD: Urology Clinics of North Texas: Investment Interest

Bruce R. Gilbert, MD, PhD: Bayer Healthcare Pharmaceuticals Inc.: Scientific Study or Trial; Auxilium: Scientific Study or Trial; Clarus Pharmaceutcals: Scientific Study or Trial; Eli Lilly: Scientific Study or Trial; Warner Chilcott: Scientific Study or Trial

Christina Hernandez (AUA Staff): Nothing to disclose

Douglas A. Husmann, MD: Nothing to disclose

Wes Kassouf, MD: Nothing to disclose

Louis Koncz, PA-C: Nothing to disclose

Cheryl Taylore Lee, MD: Adolor: Scientific Study or Trial; Tengion, Inc.: Consultant or Advisor, Scientific Study or Trial; Endo Pharmaceuticals: Consultant or Advisor, Scientific Study or Trial; Photocure: Consultant or Advisor; CVI: Consultant or Advisor

Thomas Sean Lendvay, MD: Spi Surgical Inc.: Consultant or Advisor, Owner, Product Development; MIMIC Technologies Inc.: Other

Vinata B. Lokeshwar, PhD: Nothing to disclose

Elspeth Marguerita McDougall, MD: Nothing to disclose

John Patrick Mulhall, MD: Association of Peyronie's Disease Advocates (APDA): Leadership Position; Pfizer: Scientific Study or Trial; Vivus: Consultant or Advisor, Scientific Study or Trial; Nexmed: Consultant or Advisor; Absorption Pharmaceuticals: Consultant or Advisor; AMS: Consultant or Advisor, Scientific Study or Trial; Meda: Consultant or Advisor; Lilly: Consultant or Advisor; Alliance for Fertility Preservation: Leadership Position

J. Kellogg Parsons, MD: AMS: Meeting Participant or Lecturer; Sophiris: Consultant or Advisor; Watson: Consultant or Advisor

Lee Richstone, MD: Wundercare LLC: Consultant or Advisor

Marianne D. Sadar, PhD: ESSA Pharma Inc.: Leadership Position, Consultant or Advisor, Investment Interest

Karl-Dietrich Sievert, MD, PhD: AMS: Meeting Participant or Lecturer; Karl Storz: Meeting Participant or Lecturer; Photocure: Scientific Study or Trial; Medtronics: Meeting Participant or Lecturer, Scientific Study or Trial; Allergen: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Neotract: Meeting Participant or Lecturer

Sheila Stark, PhD (AUA Staff): Nothing to disclose

William Donald Steers, MD: National Institutes of Health: Consultant or Advisor, Meeting Participant or Lecturer; Allergan: Scientific Study or Trial; New England Research Institute (NERI): Consultant or Advisor, Scientific Study or Trial

Chandru P. Sundaram, MD: Cook Medical Inc.: Scientific Study or Trial; North Central Section of the AUA: Leadership Position; Journal of Endourology and Videourology: Leadership Position; Society of Urological Robotic Surgeons: Leadership Position

Ashutosh Kumar Tewari, MD: Intuitive Surgical: Scientific Study or Trial; Kalyani Prostate Cancer Institute: Leadership Position; Global Prostate Cancer Foundation: Leadership Position; Peter Georgescu Foundation Award: Leadership Position; Chris Lange Foundation: Other; Peter Kalikow Foundation: Other; Craig Effron Foundation: Other; Tim O'Neill Foundation: Other; Patent for a Catheter-less device and approach: Other; NIH RO1 Funding-PI: Other

Paul Jacob Turek, MD: MandalMed: Leadership Position; Medical Board of California: Consultant or Advisor; BioQuiddity, Inc.: Consultant or Advisor, Investment Interest; HealthLoop.com: Consultant or Advisor, Investment Interest; Doximity, Inc.: Consultant or Advisor, Investment Interest; Fertility Planit, Inc.: Consultant or Advisor, Investment Interest

Alan J. Wein, MD, PHD (HON): Allergan: Consultant or Advisor, Meeting Participant or Lecturer; Medtronic: Consultant or Advisor, Meeting Participant or Lecturer; Ferring Pharmaceuticals: Consultant or Advisor, Meeting Participant or Lecturer; Pfizer; Consultant or Advisor, Meeting Participant or Lecturer; Astellas: Consultant or Advisor, Meeting Participant or Lecturer; Merck: Consultant or Advisor; opko: Consultant or Advisor; theravida: Consultant or Advisor

APN/PA Education Committee

Jeffrey A. Albaugh, PhD, APRN-BC, CUCNS: Sexual Medicine Society of North America: Leadership Position, Meeting Participant or Lecturer; Society of Urologic Nurses & Associates: Leadership Position, Meeting Participant or Lecturer; Prostate Net: Meeting Participant or Lecturer; Jannetti Publications Inc.: Other; Actient Pharmaceuticals LLC.: Consultant or Advisor, Meeting Participant or Lecturer; Astellas Pharma: Consultant or Advisor; Medivation: Consultant or Advisor

Roxelyn Baumgartner, RN, APN-BC: Nothing to disclose

Ashleigh Decker, PA-C: Nothing to disclose

Todd James Doran, MS, PA-C: Urological Association of Physician Assistants: Leadership Position; Physician Assistant Education Association: Leadership Position

Susan M. Flick, CNP: Pfizer: Other

Peggy Francis, DNP, RN, MSN, CS, FNP-BC, CUNP: Warner Chilcott: Meeting Participant or Lecturer

Gina Fries, RPA-C: Astellas Pharma US: Scientific Study or Trial

Raymond Matthew Galocy, ANP-C: Nothing to disclose

Michele Huebner, PA-C: Urological Association of Physician Assistants: Leadership Position

Louis Koncz, PA-C: Nothing to disclose

Ralph Raphael Madeb, MD: Nothing to disclose

Thomas P. McBride, PA-C: Adirondack Society of Physician Assistants: Leadership Position, Meeting Participant or Lecturer; Dendreon Corporation: Investment Interest; SeekingAlpha.com: Health Publishing

Heather Schultz, NP: Nothing to disclose

Allen D. Seftel, MD: Auxilium: Consultant or Advisor, Scientific Study or Trial; Journal of Urology: Leadership Position; Abbott: Consultant or Advisor; Lilly: Consultant or Advisor, Scientific Study or Trial; Journal of Sexual Medicine: Leadership Position; American Geriatrics Society: Leadership Position; Urology Care Foundation: Leadership Position; Mid-Atlantic Section of AUA: Leadership Position; AUA NPP committee: Leadership Position; International Journal of Impotence Research: Leadership Position; Patient Pocket, LLC: Owner, Product Development.

Meredith Vaccaro (AUA Staff): Nothing to disclose

Accreditation Statement

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American Urological Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. If you have already received credit for this course by attending it or watching it live you cannot receive additional credit.

Evidence-Based Content

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Off-labeled or Unapproved Use of Drugs or Devices

It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the product prescribing information for full disclosure of approved uses.

AUA Privacy and Confidentiality Policy

www.auanet.org/education/confidentiality-statement.cfm

Contact Information

American Urological Association
Office of Education
1000 Corporate Blvd.
Linthicum, MD 21090
Toll Free (U.S. only): 1-866-RING AUA (1-866-746-4282)
Phone: 410-689-3700
Fax: 410-689-3800

CME Information

For all inquiries regarding CME credit email: cme@AUAnet.org

  • ELEARNING ACTIVITIES

    Webcasts

    2013 Primary Care Update in Urology

    Strategies to Improve Adherence and Clinical Management of OAB [CME]
    (Non-AUA Activity)
    Improve your knowledge and performance related to discussions with patients about optimal treatment.

  • EDUCATIONAL COURSES

    Annual Meeting Activities

    007IC: AUA Guideline: Overactive Bladder (Non-Neurogenic) in Adults Update
    Director: E. Ann Gormley, MD
    Saturday May 17, 2014
    10 a.m. – Noon
    OCCC: W 207

    046PG: Urodynamic Evaluation and Advances in Management of Adult Neurogenic Bladder: A Case Based Approach
    Director: Hari Tunuguntla, MD
    Faculty: Angelo E. Gousse, MD | Stephen R. Kraus, MD
    Sunday May 18, 2014
    3:30 – 6:30 p.m.
    OCCC: W 209

    Urology Care by the APN/PA: Maximizing Patient Outcomes
    Directors: Jeffrey A. Albaugh, Ph.D., APRN-BC, CUCNS, Ashleigh Decker, PA-C and Gina Fries, RPA-C
    Saturday May 17, 2014
    1 – 5:15 p.m.
    OCCC: W230

    Best Practices Urologic Care for the Allied Health Professional
    Directors: Louis Koncz, PA-C and Timothy Brand, MD
    Sunday, May 18, 2014
    8 a.m. – 5 p.m.

    Primary Care Update in Urology
    Saturday May 17, 2014
    Orlando, FL

    Attend this complimentary CME activity with the latest research from expert urologists on the urologic issues most relevant to front-line patient care. This free, half-day course will enhance your knowledge to help improve patient care in the following areas:

    • Hypogonadism
    • Overactive Bladder (OAB)
    • Urologic Emergencies
    • Benign Prostatic Hyperplasia (BPH)

    Other Educational Courses

    AUA Annual Review Course
    June 5 – 8, 2014
    New Orleans, LA
    *Online Webcast Option Available After Course!

    In preparation of the American Board of Urology (ABU) Qualifying (Part 1) Examination residents need to have basic urologic knowledge to prepare them for the ABU examinations. To fulfill this need, the American Urological Association (AUA) developed this course to disseminate current urologic knowledge. This course may also be of interest to practicing urologists preparing for the Recertification Examination as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.

    AUA Basic Sciences of Urology
    June 14 – 17, 2014
    Charlottesville, VA

    The Basic Sciences of Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms. This 4-day course will provide attendees with valuable skills in developing a rational methodological approach to application of knowledge which will contribute to positive outcomes for patients. Attendees will discover the importance of the study of basic sciences and how it transfers into lifelong learning process and medical practice.

    **Optional Urodynamics Course on Friday, June 13! This seminar provides a detailed overview of urodynamic testing techniques and pitfalls including hydrodynamic principles. Emphasis is placed on the interpretation of urodynamics, including recognizing abdominal and detrusor physiologic events, urethral resistance during bladder filling and micturition, urinary incontinence, and recognition of physiologic and technical artifacts.

    Save the Date

    AUA Female Urology and Advanced Urodynamics
    November 6 – 8, 2014
    Baltimore, MD
    registration@AUAnet.org

  • VIDEOS ON AUA'S YOUTUBE PAGE

OAB Guideline

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
2012

OAB Webcasts


Dowload AUA Guidelines Apps

AUA Guidelines at a Glance
AUA Guidelines at a Glance
[ Android ]  [ Apple App Store
 
AUA Guidelines at a Glance for Primary Care Professionals
AUA Guidelines at a Glance for Primary Care Professionals
[ Android ]  [ Apple App Store
 

OAB Patient Materials from the Urology Care Foundation

The Urology Care Foundation launched the "It's Time to Talk About OAB," a nationwide education campaign designed to elevate awareness of Overactive Bladder (OAB), a common, yet often untreated condition, as a public health issue. As many as 30 percent of men and 40 percent of women in the United States have OAB. The campaign's goal is two-fold: help patients better understand OAB symptoms and de-stigmatize the condition so that patients feel comfortable initiating a conversation with their healthcare professional – ultimately leading to diagnosis and treatment.

Below are a variety of tools to help your patient understand their condition and assist them as they go through the journey of OAB diagnosis and treatment.

Tools and Information for Patients

Patient information is available online at UrologyHealth.org/OAB. For those patients with Mixed Incontinence, SUI patient education information is available at UrologyHealth.org/SUI.

You may order multiple copies to be mailed to your office at no cost from www.auanet.org/resources/patient-information.cfm, UrologyHealth.org/Order or by calling 800-828-7866.

Patient Information Materials

Do you have an Overactive Bladder (OAB)? [pdf]
Trifold brochure that describes OAB symptoms at a lower literacy level.

Frequently Asked Questions About Overactive Bladder [pdf]
A fact sheet.

Talking with your Healthcare Professional About Overactive Bladder [pdf]
A fact sheet.

A Patient's Guide to Overactive Bladder [pdf]
A comprehensive guide on OAB that includes all information in the pieces listed above.

Assessment Tools

Think You Have Overactive Bladder? Quiz
Print this simple list of questions and answer them. You can use your completed questionnaire to start the conversation with your healthcare provider about your symptoms. The questions will help you and your healthcare provider assess which OAB symptoms you have and how much they are bothering you. The better your healthcare provider understands the level and impact of your symptoms, the better he or she can help you manage them.

i. Take the Quiz

ii. Print version [pdf]

Bladder Diary
Print our Bladder Diary to record how much liquid (coffee, water, soda, etc.) you drink, how often you go to the bathroom, and when you have urine leakage. This will help your healthcare professional know when and why your symptoms occur.

Bladder Pal
The Bladder Pal is a paperless bladder diary for people whose electronic devices run Apple or Android apps. This free app lets you keep track of how much you drink, how often you go to the bathroom, and any urine leakage. It also has a questionnaire called the AUA Symptom Score, which helps assess your urinary symptoms (especially those in men with prostate problems). To share your results with your healthcare professional, you can email them to yourself and print them out.

iii. Bladder Pal app for Android

iv. Bladder Pal app for Apple

The Bladder Pal was developed by AUA Member, Dr. Ronald Yap, through the support of the LeBaron Foundation and the Concord Hospital Trust.

Information and Tools for Healthcare Providers

Helping your patients through their OAB journey starts with knowing the facts about OAB. Use the following resources to learn more.

Health Care Provider Fact Sheet: How to Talk To Your Patients About Overactive Bladder [pdf]
A fact sheet to help health care providers initiate a conversation with patients about OAB, featuring "conversation starters", tips on how to handle a "door knob moment," and OAB basics.

AUA Clinical Guideline on Overactive Bladder
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline [pdf]
2012

Diagnosis and Treatment Algorithm
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Algorithm [pdf]
2012

For referral to a urologist, use our Find A Urologist tool at UrologyHealth.org/FindAUrologist. Chose "incontinence" as a "special interest area" to find urologists who said they are interested in treating OAB and Incontinence.

For more information contact:
Urology Care Foundation
1000 Corporate Blvd.
Linthicum, MD 21090
1-800-828-7866
www.UrologyHealth.org

ADVERTISEMENT

ADVERTISEMENT
Donate
Contact
Press/Media
Sections
Term of Use
Site Map


ADVERTISEMENT